🇺🇸 Mirum Pharmaceuticals, Inc.MIRM
Get Mirum Pharmaceuticals, Inc. filings on Telegram the moment they are published.
Follow Mirum Pharmaceuticals, Inc. on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 8-K Items 8.01
Overview: Announced topline results from the Phase 3 EXPAND study showing LIVMARLI met its primary endpoint for cholestatic pruritus in ultra-rare cholestatic liver diseases.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest